Changes in standard of care (SOC) medication during long-term mavacamten treatment for obstructive hypertrophic cardiomyopathy (HCM): results from the EXPLORER cohort of MAVA-Long-Term Extension (LTE)
Event: ESC Congress 2023
Topic: Hypertrophic Cardiomyopathy
Session: Cardiomyopathies in myocardial disease
